One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.

• Main Authors: Susanna J Lake (Author), Daniel Engelman (Author), Julie Zinihite (Author), Oliver Sokana (Author), Dickson Boara (Author), Titus Nasi (Author), Christina Gorae (Author), Millicent H Osti (Author), Sophie Phelan (Author), Matthew Parnaby (Author), Anneke C Grobler (Author), Tibor Schuster (Author), Ross Andrews (Author), Margot J Whitfeld (Author), Michael Marks (Author), Lucia Romani (Author), Andrew C Steer (Author), John M Kaldor (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Mass drug administration (MDA) based on two doses of ivermectin, one week apart, substantially reduces prevalence of both scabies and impetigo. The Regimens of Ivermectin for Scabies Elimination (RISE) trial assessed whether one-dose ivermectin-based MDA would be as ef...